Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease

Summary

The purpose of this study is to determine efficacy of gabapentin vs. placebo at controlling peripheral neuropathic pain in patients with Fabry disease, and reducing their use of opioid analgesics. The investigators are conducting a randomized, double-blind, placebo controlled, single center, cross-over study. The primary endpoint is percent reduction in patients' use of hydrocodone-acetaminophen.

Timeline

Start

2012-04

Primary completion

2014-06

Completion

2014-06

Drugs

Indications